|
2024
|
Invention
|
Antibody binding to fcrn for treating autoimmune diseases.
The present disclosure relates to an ... |
|
2023
|
G/S
|
Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; to... |
|
|
G/S
|
Pharmaceutical agents affecting sensory organs; thyroid and
para-thyroid hormone preparations; t... |
|
|
G/S
|
Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and p... |
|
|
G/S
|
Reagents for use in diagnostic testing of HBS antibody for
medical purposes pharmaceutical agent... |
|
|
G/S
|
Reagents for use in diagnostic testing of HBS antibody for medical purposes pharmaceutical agents... |
|
|
Invention
|
Anti-fcrn antibody or antigen binding fragment thereof with improved stability. The present discl... |
|
|
Invention
|
Anti-fcrn antibody or antigen binding fragment thereof with improved stability |
|
2022
|
Invention
|
A stable ophthalmic composition comprising tanfanercept, which is free of stabilizer or substanti... |
|
|
Invention
|
Ophthalmic composition including tanfanercept and exhibiting stability without use of stabilizer.... |
|
2021
|
Invention
|
Formulation for anti-fcrn antibody.
In one aspect of the present invention, there is provided a ... |
|
|
Invention
|
Formulation for anti-fcrn antibody. One aspect of the present invention provides an aqueous pharm... |
|
|
Invention
|
Treatment of dry eye syndrome using an ophthalmic composition comprising tanfanercept.
The prese... |
|
|
Invention
|
Treatment of dry eye syndrome using tanfanercept ophthalmic composition. The present invention re... |
|
2019
|
Invention
|
Antibody binding to fcrn for treating autoimmune diseases. The present disclosure relates to an i... |
|
2015
|
Invention
|
Antibody binding to fcrn for treating autoimmune diseases. ABSTRACT The present disclosure relate... |
|
|
Invention
|
Compositions for external application, containing adenosylcobalamin for improvement of skin disea... |
|
2014
|
Invention
|
Fcrn-specific human antibody and composition for treatment of autoimmune diseases. The present in... |
|
|
Invention
|
N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceu... |
|
2013
|
Invention
|
Pharmaceutical composition having activity of anticancer.
Disclosed is an anticancer pharmaceuti... |
|
|
Invention
|
Bosentan controlled release oral preparation.
Provided are an extended release preparation for o... |
|
|
Invention
|
Bosentan controlled release oral preparation. The present invention provides: a bosentan controll... |
|
|
Invention
|
New uses of modified human tumor necrosis factor receptor-1 polypeptide. The present invention re... |
|
2012
|
Invention
|
Pharmaceutical composition for treating atopic dermatitis.
A method of treating mild atopic derm... |
|
|
Invention
|
N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and ph... |
|
|
Invention
|
N1-cyclic amine-n2-substituted biguanide derivatives, methods of preparing the same and pharmaceu... |
|
|
Invention
|
Pharmaceutical composition for inhibiting cancer recurrence or metastasis. The present invention ... |
|
|
Invention
|
Pharmaceutical composition for treating atopic dermatitis. A method of treating mild atopic derma... |
|
|
Invention
|
Pharmaceutical composition comprising losartin for treating or preventing statin basedgrug-induce... |
|
2011
|
Invention
|
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for p... |
|
|
Invention
|
Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for pr... |
|
|
Invention
|
N,n-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutica... |
|
|
Invention
|
Modified human tumor necrosis factor receptor-i polypeptide or fragment thereof, and method for p... |
|
|
Invention
|
Anti-cancer pharmaceutical composition.
Disclosed is an anticancer pharmaceutical composition co... |
|
|
Invention
|
Anti-cancer pharmaceutical composition. The present invention relates to an anti-cancer pharmaceu... |
|
2010
|
G/S
|
Design and development of computer hardware and software; Scientific and industrial research; Des... |
|
|
G/S
|
Pharmaceutical preparations; Medical preparations; Sanitary preparations for medical purposes; Bi... |
|
|
Invention
|
Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharm... |
|
|
Invention
|
Modified human thrombopoietin polypeptide fragment and manufacturing method thereof.
The inventi... |
|
2009
|
Invention
|
Modified erythropoietin (epo) polypeptides that exhibit increased protease resistance and pharmac... |
|
2008
|
Invention
|
1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceuti... |
|
|
Invention
|
Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manu... |
